Shepard Goldberg - Echo Therapeutics Director
Director
Mr.Shepard M. Goldberg is Independent Director of the Echo Therapeutics Inc. He was elected a director on June 19 2014. As a Principal at SMG Consulting since January 2008 Mr. Goldberg provides management consulting for small and medium size businesses. Mr. Goldberg also served as Chief Executive Officer and Director at Cordex Pharma Inc. from February 2010 to March 2012 a specialty pharmaceutical company developing new cardiovascular medicines. Prior to joining Cordex Mr. Goldberg served as Senior Vice President Operations and Office of the President at Emisphere Technologies Inc. a publicly traded biopharmaceutical company charting new frontiers in drug delivery. Prior to that Mr. Goldberg was President of Hydrovalve Co. Inc. a privately held manufacturingdistribution business with national and international catalog sales since 2014.
| Age | 59 |
| Tenure | 10 years |
| Phone | 732-201-4189 |
| Web | http://www.echotx.com |
Echo Therapeutics Management Efficiency
The company has return on total asset (ROA) of (359.77) % which means that it has lost $359.77 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.649) %, meaning that it created substantial loss on money invested by shareholders. Echo Therapeutics' management efficiency ratios could be used to measure how well Echo Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 3.52 M in liabilities with Debt to Equity (D/E) ratio of 0.03, which may suggest the company is not taking enough advantage from borrowing. Echo Therapeutics has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Echo Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Echo Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Echo Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Echo to invest in growth at high rates of return. When we think about Echo Therapeutics' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Prattipati Laxminarain | Microbot Medical | 59 | |
| Daniel Gill | Asure Software | 53 | |
| Matthew Cohler | Uber Technologies | 43 | |
| Garrett Camp | Uber Technologies | 44 | |
| Adrian Pertierra | Asure Software | 45 | |
| Solomon Mayer | Microbot Medical | 62 | |
| Randall Waterfield | Asure Software | 43 | |
| Kevin Kotler | Avadel Pharmaceuticals PLC | 45 | |
| Travis Kalanick | Uber Technologies | 41 | |
| David Trujillo | Uber Technologies | 45 | |
| Christophe Navarre | Avadel Pharmaceuticals PLC | ||
| John Thain | Uber Technologies | 65 | |
| Moshe Shoham | Microbot Medical | 64 | |
| Amanda Ginsberg | Uber Technologies | 51 | |
| Guillaume Cerutti | Avadel Pharmaceuticals PLC | 49 | |
| Ryan Graves | Uber Technologies | 34 | |
| Yoseph Bornstein | Microbot Medical | 65 | |
| Matthew Behrent | Asure Software | 46 | |
| Ursula Burns | Uber Technologies | 62 | |
| Francis Fildes | Avadel Pharmaceuticals PLC | 71 | |
| Yasir AlRumayyan | Uber Technologies | 50 | |
Management Performance
| Return On Equity | -3.65 | |||
| Return On Asset | -359.77 |
Echo Therapeutics Leadership Team
Elected by the shareholders, the Echo Therapeutics' board of directors comprises two types of representatives: Echo Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Echo. The board's role is to monitor Echo Therapeutics' management team and ensure that shareholders' interests are well served. Echo Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Echo Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Goldberg, Director | ||
| Scott Hollander, CEO and President and Director | ||
| Elazer Edelman, Director | ||
| Christine Olimpio, Director of Investor Relations and Corporate Communications | ||
| Alan Schoenbart, CFO | ||
| Shepard Goldberg, Director |
Echo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Echo Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -3.65 | |||
| Return On Asset | -359.77 | |||
| Current Valuation | 3.43 M | |||
| Shares Outstanding | 12 M | |||
| Number Of Shares Shorted | 273.27 K | |||
| Price To Earning | (0.03) X | |||
| Price To Book | 3.11 X | |||
| Price To Sales | 990.09 X | |||
| Revenue | 5.12 K | |||
| Gross Profit | 5.12 K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Echo Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Echo Therapeutics' short interest history, or implied volatility extrapolated from Echo Therapeutics options trading.
Pair Trading with Echo Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Echo Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Echo Therapeutics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Lennar could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lennar when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lennar - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lennar to buy it.
The correlation of Lennar is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lennar moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lennar moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lennar can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Echo Stock
If you are still planning to invest in Echo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Echo Therapeutics' history and understand the potential risks before investing.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |